Literature DB >> 27344639

Noble metal nanoparticle-induced oxidative stress modulates tumor associated macrophages (TAMs) from an M2 to M1 phenotype: An in vitro approach.

Ramkrishna Pal1, Biswajit Chakraborty1, Anupam Nath1, Leichombam Mohindro Singh1, Mohammed Ali2, Dewan Shahidur Rahman2, Sujit Kumar Ghosh2, Abhishek Basu3, Sudin Bhattacharya3, Rathindranath Baral4, Mahuya Sengupta5.   

Abstract

Diagnosis of cancer and photothermal therapy using optoelectronic properties of noble metal nanoparticles (NPs) has established a new therapeutic approach for treating cancer. Here we address the intrinsic properties of noble metal NPs (gold and silver) as well as the mechanism of their potential antitumor activity. For this, the study addresses the functional characterization of tumor associated macrophages (TAMs) isolated from murine fibrosarcoma induced by a chemical carcinogen, 3-methylcholanthrene (MCA). We have previously shown antitumor activity of both gold nanoparticles (AuNPs) and silver nanoparticle (AgNPs) in vivo in a murine fibrosarcoma model. In the present study, it has been seen that AuNPs and AgNPs modulate the reactive oxygen species (ROS) and reactive nitrogen species (RNS) production, suppressing the antioxidant system of cells (TAMs). Moreover, the antioxidant-mimetic action of these NPs maintain the ROS and RNS levels in TAMs which act as second messengers to activate the proinflammatory signaling cascades. Thus, while there is a downregulation of tumor necrosis factor-α (TNF-α) and Interleukin-10 (IL-10) in the TAMs, the proinflammatory cytokine Interleukin-12 (IL-12) is upregulated resulting in a polarization of TAMs from M2 (anti-inflammatory) to M1 (pro-inflammatory) nature.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  Chemical carcinogen; Gold nanoparticles; Noble metal nanoparticles; RNS; ROS; Silver nanoparticles; TAMs

Mesh:

Substances:

Year:  2016        PMID: 27344639     DOI: 10.1016/j.intimp.2016.06.006

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  15 in total

1.  Anticancer efficacy of noble metal nanoparticles relies on reprogramming tumor-associated macrophages through redox pathways and pro-inflammatory cytokine cascades.

Authors:  Mahuya Sengupta; Ramkrishna Pal; Anupam Nath; Biswajit Chakraborty; Leichombam Mohindro Singh; Biswajit Das; Sujit Kumar Ghosh
Journal:  Cell Mol Immunol       Date:  2018-05-24       Impact factor: 11.530

Review 2.  Nanomedicines for dysfunctional macrophage-associated diseases.

Authors:  Hongliang He; Shobha Ghosh; Hu Yang
Journal:  J Control Release       Date:  2017-01-03       Impact factor: 9.776

3.  Spatiotemporal Tracking of Brain-Tumor-Associated Myeloid Cells in Vivo through Optical Coherence Tomography with Plasmonic Labeling and Speckle Modulation.

Authors:  Elliott Daniel SoRelle; Derek William Yecies; Orly Liba; Frederick Christian Bennett; Claus Moritz Graef; Rebecca Dutta; Siddhartha Mitra; Lydia-Marie Joubert; Samuel Cheshier; Gerald A Grant; Adam de la Zerda
Journal:  ACS Nano       Date:  2019-07-01       Impact factor: 15.881

4.  Gold nanoparticle-directed autophagy intervention for antitumor immunotherapy via inhibiting tumor-associated macrophage M2 polarization.

Authors:  Siyue Zhang; Fangyuan Xie; Kaichun Li; He Zhang; You Yin; Yuan Yu; Guangzhao Lu; Shihao Zhang; Yan Wei; Ke Xu; Yan Wu; Hong Jin; Lan Xiao; Leilei Bao; Can Xu; Yulin Li; Ying Lu; Jie Gao
Journal:  Acta Pharm Sin B       Date:  2022-02-16       Impact factor: 14.903

5.  Biodistribution of gold nanoparticles in BBN-induced muscle-invasive bladder cancer in mice.

Authors:  Henry M Smilowitz; Lauren J Tarmu; Mary Melinda Sanders; John A Taylor; Dharamainder Choudhary; Crystal Xue; Nathaniel A Dyment; Dan Sasso; Xiaomeng Deng; James F Hainfeld
Journal:  Int J Nanomedicine       Date:  2017-10-27

6.  Antitumor Activity of Alloy and Core-Shell-Type Bimetallic AgAu Nanoparticles.

Authors:  Igor Shmarakov; Iuliia Mukha; Nadiia Vityuk; Vira Borschovetska; Nelya Zhyshchynska; Galyna Grodzyuk; Anna Eremenko
Journal:  Nanoscale Res Lett       Date:  2017-05-04       Impact factor: 4.703

7.  Targeted delivery of nano-PTX to the brain tumor-associated macrophages.

Authors:  Lei Zou; Youhua Tao; Gregory Payne; Linh Do; Tima Thomas; Juan Rodriguez; Huanyu Dou
Journal:  Oncotarget       Date:  2017-01-24

8.  LncRNA BCRT1 promotes breast cancer progression by targeting miR-1303/PTBP3 axis.

Authors:  Yiran Liang; Xiaojin Song; Yaming Li; Bing Chen; Wenjing Zhao; Lijuan Wang; Hanwen Zhang; Ying Liu; Dianwen Han; Ning Zhang; Tingting Ma; Yajie Wang; Fangzhou Ye; Dan Luo; Xiaoyan Li; Qifeng Yang
Journal:  Mol Cancer       Date:  2020-05-08       Impact factor: 27.401

Review 9.  Exploiting a New Approach to Destroy the Barrier of Tumor Microenvironment: Nano-Architecture Delivery Systems.

Authors:  Yanting Sun; Yuling Li; Shuo Shi; Chunyan Dong
Journal:  Molecules       Date:  2021-05-05       Impact factor: 4.411

Review 10.  Redox control of cancer cell destruction.

Authors:  Csaba Hegedűs; Katalin Kovács; Zsuzsanna Polgár; Zsolt Regdon; Éva Szabó; Agnieszka Robaszkiewicz; Henry Jay Forman; Anna Martner; László Virág
Journal:  Redox Biol       Date:  2018-02-03       Impact factor: 11.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.